Just a month after Andrew Witty’s announcement that GSK will make more than 13,500 of its malaria compounds available to all, Pfizer, Merck, and Eli Lilly have thrown their do-gooder hats into the ring as well.
Together, the three drug giants will pull together an undisclosed dollar amount in seed funding and create the independent, non-profit [...]
PharmExec Blog
Follow Us
RSS
Bookstore
Merck, Lilly, Pfizer: One for All and All for One